Oligodendroglial glycolipids in (Re)myelination: implications for multiple sclerosis research.
Nat Prod Rep
; 38(5): 890-904, 2021 05 26.
Article
en En
| MEDLINE
| ID: mdl-33575689
Covering: up to 2020 This short review surveys aspects of glycolipid-based natural products and their biological relevance in multiple sclerosis (MS). The role of isolated gangliosides in disease models is discussed together with an overview of ganglioside-inspired small molecule drugs and imaging probes. The discussion is extended to neurodegeneration in a more general context and addresses the need for more efficient synthetic methods to generate (glyco)structures that are of therapeutic relevance.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Glucolípidos
/
Oligodendroglía
/
Gangliósidos
/
Esclerosis Múltiple
Límite:
Humans
Idioma:
En
Revista:
Nat Prod Rep
Asunto de la revista:
QUIMICA
Año:
2021
Tipo del documento:
Article
País de afiliación:
Alemania
Pais de publicación:
Reino Unido